Dr Reddy’s Laboratories launches generic semaglutide injection in Canada

Dr Reddy’s said it is among the first to introduce a generic semaglutide injection in the Canadian market after it received the Notice of Compliance (NOC) from Health Canada on April 28, 2026.

Leave a Reply

Your email address will not be published. Required fields are marked *